We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Biodel Completes Enrollment of Two Pivotal Phase III Clinical Trials of VIAject™ and Plans Manufacturing Facility for VIAject™

News   Jan 08, 2008

 
Biodel Completes Enrollment of Two Pivotal Phase III Clinical Trials of VIAject™ and Plans Manufacturing Facility for VIAject™
 
 
 

RELATED ARTICLES

Scorpion Venom Can Shuttle Drugs into the Brain

News

Researchers at IRB Barcelona modify chlorotoxin—a small protein present in scorpion venom with blood-brain barrier permeability—to transport drugs into the brain.

READ MORE

Biopatch Delivers Exact Drug Doses Directly into Cells

News

Minimally invasive patch developed by Purdue researchers delivers exact doses directly into cells, lessens pain and toxicity.

READ MORE


 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE